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The activation of pro-inflammatory gene programs by nuclear factor-kB (NF-kB) is primarily regulated through cytoplasmic sequestration of NF-kB by the inhibitor of kB (IkB) family of proteins 1 . IkBb, a major isoform of IkB, can sequester NF-kB in the cytoplasm 2 , although its biological role remains unclear. Although cells lacking IkBb have been reported 3, 4 , in vivo studies have been limited and suggested redundancy between IkBa and IkBb 5 . Like IkBa, IkBb is also inducibly degraded; however, upon stimulation by lipopolysaccharide (LPS), it is degraded slowly and re-synthesized as a hypophosphorylated form that can be detected in the nucleus [6] [7] [8] [9] [10] [11] . The crystal structure of IkBb bound to p65 suggested this complex might bind DNA 12 . In vitro, hypophosphorylated IkBb can bind DNA with p65 and c-Rel, and the DNA-bound NF-kB:IkBb complexes are resistant to IkBa, suggesting hypophosphorylated, nuclear IkBb may prolong the expression of certain genes [9] [10] [11] . Here we report that in vivo IkBb serves both to inhibit and facilitate the inflammatory response. IkBb degradation releases NF-kB dimers which upregulate proinflammatory target genes such as tumour necrosis factor-a (TNF-a). Surprisingly, absence of IkBb results in a dramatic reduction of TNF-a in response to LPS even though activation of NF-kB is normal. The inhibition of TNF-a messenger RNA (mRNA) expression correlates with the absence of nuclear, hypophosphorylated-IkBb bound to p65:c-Rel heterodimers at a specific kB site on the TNF-a promoter. Therefore IkBb acts through p65:c-Rel dimers to maintain prolonged expression of TNF-a. As a result, IkBb 2/2 mice are resistant to LPS-induced septic shock and collagen-induced arthritis. Blocking IkBb might be a promising new strategy for selectively inhibiting the chronic phase of TNF-a production during the inflammatory response.
To understand the biological function of IkBb better, we studied mice lacking the IkBb gene. Homologous recombination was used to delete most of the IkBb coding sequences (30-308 amino acids) including elements essential for binding to NF-kB ( Supplementary  Fig. 2 ) 6, 12, 13 . Absence of IkBb was confirmed by immunoblotting of mouse embryonic fibroblasts (MEFs; Supplementary Fig. 2 ). Although IkBb is expressed broadly, including in haematopoietic organs ( Supplementary Fig. 3a) , the IkBb knockout mice breed and develop normally without any obvious phenotypic defects.
NF-kB and IkB proteins function in an integrated network. Hence reduced expression of one component may cause compensatory changes in levels of other proteins 14, 15 . However, expression levels of IkBa, IkBe, p65, RelB, c-Rel, p105 and p100 were unaffected in IkBb 2/2 mice ( Supplementary Fig. 3b ). Increased NF-kB activity has been observed in other IkB knockouts [16] [17] [18] , and increased basal NFkB reporter activity was observed in IkBb 2/2 MEFs (Fig. 1a) . Electrophoretic mobility shift assays (EMSAs) demonstrated increased basal NF-kB activity in IkBb 2/2 cells (60%) (Supplementary Fig. 3c ). Conversely, overexpression of IkBb inhibits NF-kB activation ( Supplementary Fig. 3d ). Thus IkBb inhibits NF-kB and degradation or loss of IkBb contributes to NF-kB activity. NF-kB reporter assays reveal that absolute NF-kB activity in response to LPS, IL-1b or TNF-a is slightly higher in the IkBb 2/2 than wild-type cells (Fig. 1a) . However, the kinetics of NF-kB activation by EMSA, and the pattern of IkB degradation by immunoblotting, in cells stimulated with LPS, IL-1b or TNF-a were not demonstrably different in IkBb 2/2 cells ( Supplementary Fig. 4 ). Thus, loss of IkBb results in a modest elevation in basal NF-kB activity, whereas inducible NF-kB activation is relatively unaffected.
NF-kB regulates the expression of many genes, in particular those involved in inflammation and immune responses 19 . To determine whether IkBb has a role in the inflammatory response, IkBb 2/2 and IkBb 1/1 mice were challenged with LPS. Surprisingly, IkBb 2/2 mice were significantly resistant to the induction of shock (Fig. 1b) . We therefore examined the serum levels of the key acute phase cytokines TNF-a, IL-1b and IL-6 (ref. 20) after LPS injection. In wild-type mice TNF-a production peaked 1 h after LPS injection, whereas IL-6 and IL-1b production peaked around 2 h, in agreement with previous studies 21 . Although serum IL-6 and IL-1b were reduced (approximately 25%) in the IkBb 2/2 mice, the reduction of TNF-a levels (greater than 70%) was more striking (Fig. 1c) . As the peak of serum TNF-a precedes that of IL-1b and IL-6, it is likely that the reduction of IL-1b and IL-6 is secondary. As monocytes and macrophages are major sources of systemic TNF-a, we analysed LPS-induced cytokines in thioglycollate-elicited peritoneal macrophages (TEPMs). Although equivalent macrophage populations were obtained from the mice (Supplementary Fig. 5a ), production of TNF-a, but not IL-6, was drastically reduced in IkBb 2/2 TEPMs (Fig. 1d ). To understand how IkBb affects TNF-a synthesis we examined each step of TNF-a production. Secreted TNF-a was detectable by enzyme-linked immunosorbent assay (ELISA) after 2 h of LPS stimulation and by 4 h was significantly impaired in IkBb 2/2 TEPMs (Fig. 2a) . IL-6 production was equivalent (Fig. 2a) . We examined the level of pro-TNF-a by intracellular fluorescence-activated cell sorting and found there was very little pro-TNF-a detected in the IkBb 2/2 TEPMs, even after 8 h of LPS stimulation (Fig. 2b) . The average amount of pro-TNF-a produced was two-to threefold higher in wild-type than IkBb 2/2 TEPMs (Fig. 2c) . Consistent with this difference in protein levels, steady-state TNF-a mRNA was decreased two-to sixfold in the IkBb 2/2 TEPMs compared with wild-type cells (Fig. 2d) . Although TNF-a mRNA is known to be regulated posttranscriptionally 22, 23 , there was no difference in TNF-a mRNA stability between wild-type and IkBb 2/2 TEPMs ( Supplementary  Fig. 5b ). Therefore, IkBb promotes TNF-a transcription.
To understand how IkBb affects TNF-a transcription, we investigated which NF-kB subunits were associated with IkBb in macrophages. It is known that IkBb associates with p65:p50 and c-Rel:p50 complexes 24 through direct binding to p65 and c-Rel but not p50 (ref. 6). However, we found that IkBb could be immunoprecipitated only with p65 and c-Rel, but not p50 ( (Fig. 3c ).
The IkBb:p65:c-Rel complex was found in nuclear extracts, which suggests that this could be a transcriptionally active complex. We had previously reported 10 that IkBb exists in two phosphorylation states: a hyperphosphorylated state in quiescent, unstimulated cells, and a hypophosphorylated newly synthesized state in LPS-stimulated cells ( Supplementary Fig. 6a ). In the co-immunoprecipitation experiments shown here we found that both forms of IkBb can bind p65 and c-Rel, although the hypophosphorylated form predominates in the IkBb:p65:cRel complex after LPS stimulation.
There are four kB sites upstream of TNF-a coding region, three of which are crucial for NF-kB-dependent TNF-a expression 25 . Therefore, we performed chromatin immunoprecipitation with anti-p65, anti-cRel and anti-IkBb antibodies in RAW264.7 cells and monitored the region encompassing these three kB sites. After LPS stimulation, TNFa promoter region DNA is enriched by p65, c-Rel and IkBb antibodies by 56-, 70-and 7-fold respectively (Fig. 3d) . In contrast, IkBb is not recruited to the IL-6 promoter after LPS stimulation whereas p65 and c-Rel are recruited as expected (Fig. 3d) . Recruitment of p65, c-Rel and IkBb to the TNF-a promoter was also confirmed in wild-type bonemarrow-derived macrophages (BMDMs; Fig. 3e ). In the IkBb 2/2 BMDM, both p65 and c-Rel are recruited normally to the TNF-a promoter. However, when we performed immunoprecipitation with anti-p65, c-Rel and IkBb are pulled down in wild-type but not IkBb
2/2
BMDMs (Fig. 3f) . Therefore, p65 and c-Rel fail to form a stable complex in IkBb 2/2 cells. Thus, the p65 and c-Rel recruited to the TNF-a promoter in IkBb 2/2 cells are not a p65:c-Rel complex. These data suggest that optimal TNF-a transcription requires a ternary complex of IkBb:p65:c-Rel binding to the TNF-a promoter.
To identify the kB site for p65:c-Rel binding we performed EMSAs using the three kB sites from the TNF-a promoter as probes (kB2, kB2a and kB3; Supplementary Fig. 6b ). We identified two distinct gel-shift patterns. kB3 and kB2a show two major bands (only kB3 is shown in Fig. 3g ) whereas kB2 shows three major inducible shift bands. The components of the bands were identified by super-shift assay (Fig. 3g, right panel) . The top band in the kB2 gel-shift is mostly p65:c-Rel. Interestingly, the kB2 site possesses features predicted to favour p65:c-Rel binding (Supplementary Fig. 6c ). Similar kB binding sites in the CD40 and CXCL1 promoters also demonstrated coordinate recruitment of IkBb, p65 and c-Rel ( Supplementary  Fig. 6d ). Furthermore, deletion of the kB2 site from a TNF-a promoter reporter abrogated IkBb-dependent reporter gene expression ( Supplementary Fig. 7 ). In IkBb 2/2 BMDMs, the p65:c-Rel complex binding to the kB2 in EMSA assays is missing (Fig. 3h) , in agreement with the immunoprecipitation result. Therefore optimal TNF-a transcription requires a p65:c-Rel complex, stabilized by hypophosphorylated IkBb, binding to the kB2 site in the TNF-a promoter.
To identify other genes affected by IkBb deficiency, we examined gene expression profiles in wild-type and IkBb 2/2 BMDMs (Fig. 4a) . As expected, TNF-a and IkBb are among the genes whose expression is affected by IkBb deficiency whereas IL-6 and IL-1b are not affected (Fig. 4b) . Of the genes whose expression is reduced in the IkBb 2/2 cells, we identified 14 with expression patterns resembling TNF-a (Fig. 4b) . The expression of these genes was also reduced in p65, c-Rel or p65/c-Rel knockout fetal liver macrophages, which suggests that LPS-induced expression of these genes might depend on a mechanism similar to TNF-a (data not shown). The expression of TNF-a, IL-1a, IL-6 and IL-1b in response to LPS was further examined by RNase protection (Fig. 4c ) and reverse transcription with quantitative real-time PCR (qRT-PCR) ( Supplementary Fig. 8 ), which demonstrated that the reduction in persistent expression of TNF-a in IkBb 2/2 cells is unique. Reduced IL12b mRNA and protein secretion in the knockout TEPMs was confirmed by qRT-PCR (Fig. 4d) and ELISA (Fig. 4e) . Notably, transcription of IL12b, which has a kB site similar to kB2 of TNF-a ( Supplementary Fig. 6c) , has previously been shown to require c-Rel and be partly dependent on p65 (ref. 26) . Thus, only a select group of NF-kB-dependent genes are diminished similarly to TNF-a upon IkBb deletion. As TNF-a plays a key role in inflammation, we wanted to test whether IkBb 2/2 deletion would affect the course of inflammatory diseases. . f, BMDMs treated as in e were immunoprecipitated with anti-p65 antibody. g, RAW264.7 were treated with LPS and nuclear extracts were subjected to EMSA with TNF-a kB3 or kB2 probes. Super shifts were performed using cells stimulated for 1 h. h, BMDMs were treated with LPS and EMSA and supershifts with the kB2 probe were performed as in g.
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Rheumatoid arthritis is a common inflammatory disease with morbidity resulting from ongoing release of pro-inflammatory cytokines, including TNF-a, and consequent destruction of joint tissue 27 . Previous studies have shown that NF-kB plays a key role in mouse models of arthritis and that blocking NF-kB has a dramatic effect in preventing disease 28, 29 . Rheumatoid arthritis can also be effectively treated by anti-TNF-a therapies, although there are significant sideeffects 30 . The ability to block only persistent TNF-a expression would be therapeutic without blocking beneficial TNF-a responses, including the expression of innate immune response genes. We therefore tested whether the lack of IkBb altered the course of collagen-induced arthritis, a well-characterized mouse model of rheumatoid arthritis.
To induce collagen-induced arthritis, we immunized DBA/1J mice with bovine type II collagen. IkBb 2/2 mice displayed delayed onset, lower incidence and decreased severity of collagen-induced arthritis ( Fig. 4f and Supplementary Fig. 9 ). Inflammation in the wild-type mice extended from the paws and digits to the ankle joints and distally through the limb (data not shown). In contrast, IkBb 2/2 mice showed minimal visual signs of paw and joint swelling ( Supplementary Fig. 9c ). Serum TNF-a was markedly decreased in IkBb 2/2 mice whereas other pro-inflammatory cytokines were not significantly affected ( Fig. 4g and Supplementary Fig. 10 ). Therefore the absence of IkBb limits the progression and severity of arthritis by reducing the chronic production of TNF-a.
The results presented above demonstrate a dual role for IkBb: during the early stages of LPS stimulation, NF-kB complexes released by IkBb degradation contribute to the initial expression of TNF-a ( Supplementary Fig. 1 ). Then, newly synthesized hypophosphorylated IkBb facilitates the formation of IkBb:p65:c-Rel complexes, which selectively bind to the kB2 site in the TNF-a promoter, augmenting transcription. As shown in the gene chip and RNase protection assays, this is a relatively selective function and IkBb 2/2 mice are, therefore, otherwise normal. Hence targeting IkBb might be a promising new strategy to treat chronic inflammatory diseases such as arthritis.
METHODS SUMMARY
Mice. IkBb-deficient mice were generated by standard homologous recombination in the CJ7 ES cell line using a targeting construct that replaced exons 2 to 5 with a G418-resistance gene. Screened ES cell clones were injected into blastocysts derived from C57BL/6 mice to give rise to IkBb 2/1 /IkBb 1/1 chimaeras. Germline transmission of the disrupted allele was obtained and verified by Southern blotting and PCR, and mice were backcrossed at least ten generations onto the C57BL/6 background. Mice were backcrossed at least eight generations onto the DBA background for collagen-induced arthritis experiments. Mice were maintained in pathogen-free animal facilities at Yale Medical School. Cells. Wild-type and IkBb knockout MEFs were generated from embryos at embryonic day 12.5 after timed breeding of IkBb 1/2 animals. TEPMs were obtained from 6-to 8-week-old littermate mice 3 days after intraperitoneal injection with thioglycollate. BMDMs were collected by standard protocols and differentiated with 30% L929 supernatant-conditioned media. Biochemistry. Cell fractionation, western blotting, EMSA, and immunoprecipitations were performed as previously described unless otherwise indicated 6 . LPS-induced shock. LPS-induced shock was tested by intraperitoneal injection of 50 mg g 21 body weight LPS and monitoring for survival. In a separate identical experiment, the mice were bled at 1 h and 2 h after LPS treatment and the concentrations of TNF-a, IL-6 and IL-1b in the serum were measured by ELISA. Intracellular cytokine analysis. Pro-TNF-a levels were analysed in TEPMs after LPS stimulation and brefeldin-A treatment. TNF-a was detected after cell permeabilization by using standard intracellular cytokine staining and flow cytometry. qRT-PCR. RNA expression was quantified by two-step SYBR qRT-PCR, and relative mRNA levels were obtained by normalizing the readout for each specific gene by that of b-actin. Microarray analysis. Microarrays for gene expression analyses were performed on BMDMs stimulated with LPS and Affymetrix Mouse Genome 430A 2.0 arrays as per the manufacturer's protocol.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. 
